Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2018 Jun;10(6):516-524.
doi: 10.1136/neurintsurg-2017-013328. Epub 2017 Sep 29.

TREVO stent-retriever mechanical thrombectomy for acute ischemic stroke secondary to large vessel occlusion registry

Osama O Zaidat  1   2 , Alicia C Castonguay  3 , Raul G Nogueira  4 , Diogo C Haussen  4 , Joey D English  5 , Sudhakar R Satti  6 , Jennifer Chen  7 , Hamed Farid  8 , Candace Borders  9 , Erol Veznedaroglu  10 , Mandy J Binning  10 , Ajit Puri  11 , Nirav A Vora  12 , Ron F Budzik  12 , Guilherme Dabus  13 , Italo Linfante  13 , Vallabh Janardhan  14 , Amer Alshekhlee  15 , Michael G Abraham  16 , Randall Edgell  17 , Muhammad Asif Taqi  18 , Ramy El Khoury  19 , Maxim Mokin  20 , Aniel Q Majjhoo  21 , Mouhammed R Kabbani  22 , Michael T Froehler  23 , Ira Finch  24 , Sameer A Ansari  25 , Roberta Novakovic  26 , Thanh N Nguyen  27
Affiliations
Multicenter Study

TREVO stent-retriever mechanical thrombectomy for acute ischemic stroke secondary to large vessel occlusion registry

Osama O Zaidat et al. J Neurointerv Surg. 2018 Jun.

Abstract

Background: Recent randomized clinical trials (RCTs) demonstrated the efficacy of mechanical thrombectomy using stent-retrievers in patients with acute ischemic stroke (AIS) with large vessel occlusions; however, it remains unclear if these results translate to a real-world setting. The TREVO Stent-Retriever Acute Stroke (TRACK) multicenter Registry aimed to evaluate the use of the Trevo device in everyday clinical practice.

Methods: Twenty-three centers enrolled consecutive AIS patients treated from March 2013 through August 2015 with the Trevo device. The primary outcome was defined as achieving a Thrombolysis in Cerebral Infarction (TICI) score of ≥2b. Secondary outcomes included 90-day modified Rankin Scale (mRS), mortality, and symptomatic intracranial hemorrhage (sICH).

Results: A total of 634patients were included. Mean age was 66.1±14.8 years and mean baseline NIH Stroke Scale (NIHSS) score was 17.4±6.7; 86.7% had an anterior circulation occlusion. Mean time from symptom onset to puncture and time to revascularization were 363.1±264.5 min and 78.8±49.6 min, respectively. 80.3% achieved TICI ≥2b. 90-day mRS ≤2 was achieved in 47.9%, compared with 51.4% when restricting the analysis to the anterior circulation and within 6 hours (similar to recent AHA/ASA guidelines), and 54.3% for those who achieved complete revascularization. The 90-day mortality rate was 19.8%. Independent predictors of clinical outcome included age, baseline NIHSS, use of balloon guide catheter, revascularization, and sICH.

Conclusion: The TRACK Registry results demonstrate the generalizability of the recent thrombectomy RCTs in real-world clinical practice. No differences in clinical and angiographic outcomes were shown between patients treated within the AHA/ASA guidelines and those treated outside the recommendations.

Keywords: mechanical; revascularization; stent-retriever; stroke; thrombectomy; trevo.

PubMed Disclaimer

Conflict of interest statement

Competing interests: IL is consultant for Metronic, Stryker, Penumbra, and Cordis. MM is consultant for Claret Medical, Nogueira-Stryker Neurovascular (Trevo-2 Trial Principal Investigator – modest; DAWN Trial Principal Investigator – no compensation, TREVO Registry Steering Committee – no compensation), Medtronic (SWIFT Trial Steering Committee – modest; SWIFT-Prime Trial Steering Committee – no compensation; STAR Trial Angiographic Core Lab – significant), Penumbra (3D Separator Trial Executive Committee – no compensation), Neuravi (ARISE-2 Steering Committee – no compensation), Genentech (Physician Advisory Board – modest), Allm Inc (Physician Advisory Board – no compensation), Editor-In-Chief Interventional Neurology Journal (no compensation). SRS is a consultant for Stryker Neurovascular. OOZ is overall PI for TRACK – no compensation, Arise II – modest, Co-PI Therapy Trial – modest, Steering committee STRATIS registry – modest.

Figures

Figure 1
Figure 1
TRACK Registry Flow Chart.
Figure 2
Figure 2
TRACK Registry key time metrics and outcomes. (A) Key time metrics. (B) Distribution of patients according to Tme of Onset to Groin puncture (TOG) and percentage of good clinical outcome in each stratum. (C) Distribution of 90-day modified Rankin Scale (mRS) scores in the TRACK Registry, AHA/ASA, non-AHA/ASA, and true First Pass Effect (tFPE) cohorts. The bar indicates patients with a good clinical outcome (mRS ≤2). tFPE is defined as TICI 3 on the first pass with no use of rescue therapy.
Figure 3
Figure 3
Forest plot of univariate predictors of clinical outcome dichotomized as mRS 0–2. OR (95% CI) are depicted to the right of the figure. Red and black bars indicate variables which are significant.
Figure 4
Figure 4
(A–D) Probability of ordinal modified Rankin Scale (mRS) with key clinical and technical factors. Note the highest probability of mRS 1 with younger age, lower initial NIHSS, shorter revascularization time, and smaller number of passes; mRS 3 is not a discriminator. An inverse effect was noted at the other extremes, with a higher probability of mRS 6 with older age, higher initial NIHSS, longer revascularization time, and higher number of passes.
See this image and copyright information in PMC

References

    1. English JD, Yavagal DR, Gupta R, et al. . Mechanical thrombectomy-ready comprehensive stroke center requirements and endovascular stroke systems of care: recommendations from the Endovascular Stroke Standards Committee of the Society of Vascular and Interventional Neurology (SVIN). Interv Neurol 2016;4:138–50. 10.1159/000442715 - DOI - PMC - PubMed
    1. Powers WJ, Derdeyn CP, Biller J, et al. . American Heart Association/American Stroke Association focused update of the 2013 guidelines for the early management of patients with acute ischemic stroke regarding endovascular treatment: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2015;2015:3020–35. - PubMed
    1. Berkhemer OA, Fransen PS, Beumer D, et al. . A randomized trial of intraarterial treatment for acute ischemic stroke. N Engl J Med 2015;372:11–20. 10.1056/NEJMoa1411587 - DOI - PubMed
    1. Goyal M, Demchuk AM, Menon BK, et al. . Randomized assessment of rapid endovascular treatment of ischemic stroke. N Engl J Med 2015;372:1019–30. 10.1056/NEJMoa1414905 - DOI - PubMed
    1. Campbell BCV, Donnan GA, Lees KR, et al. . Endovascular stent thrombectomy: the new standard of care for large vessel ischaemic stroke. Lancet Neurol 2015;14:846–54. 10.1016/S1474-4422(15)00140-4 - DOI - PubMed

Publication types